Successful treatment of a child having generalized Kaposi's sarcoma after living donor liver transplantation with conversion to sirolimus.
Pediatr Transplant
; 13(3): 375-8, 2009 May.
Article
em En
| MEDLINE
| ID: mdl-18452496
ABSTRACT
SRL is a new and potent immunosuppressive agent that has been successfully introduced in organ transplantation. In contrast to other immunosuppressive agents, SRL has a potent antitumor activity both in vitro and in vivo. Herein, we report a child with Kaposi's sarcoma that was diagnosed 30 months after LDLT and treated successfully with only conversion to SRL monotherapy. KS regressed completely at the end of the first month and remained in remission during 28 months follow-up.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Sarcoma de Kaposi
/
Transplante de Fígado
/
Hospedeiro Imunocomprometido
/
Sirolimo
/
Imunossupressores
/
Antibióticos Antineoplásicos
Tipo de estudo:
Etiology_studies
Limite:
Female
/
Humans
/
Infant
Idioma:
En
Ano de publicação:
2009
Tipo de documento:
Article